{"count":35518,"next":"https://panelapp-aus.org/api/v1/genes/?format=json&page=310","previous":"https://panelapp-aus.org/api/v1/genes/?format=json&page=308","results":[{"gene_data":{"alias":["RP39"],"biotype":"protein_coding","hgnc_id":"HGNC:12601","gene_name":"usherin","omim_gene":["608400"],"alias_name":null,"gene_symbol":"USH2A","hgnc_symbol":"USH2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"1:215796236-216596738","ensembl_id":"ENSG00000042781"}},"GRch38":{"90":{"location":"1:215622894-216423396","ensembl_id":"ENSG00000042781"}}},"hgnc_date_symbol_changed":"1990-03-06"},"entity_type":"gene","entity_name":"USH2A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["20507924","9624053","15015129","20301515","36041150","34331125"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Usher syndrome, type 2A, MIM#276901"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["DFFRX","FAF","MRX99"],"biotype":"protein_coding","hgnc_id":"HGNC:12632","gene_name":"ubiquitin specific peptidase 9, X-linked","omim_gene":["300072"],"alias_name":null,"gene_symbol":"USP9X","hgnc_symbol":"USP9X","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:40944888-41095832","ensembl_id":"ENSG00000124486"}},"GRch38":{"90":{"location":"X:41085635-41236579","ensembl_id":"ENSG00000124486"}}},"hgnc_date_symbol_changed":"1999-02-01"},"entity_type":"gene","entity_name":"USP9X","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["31443933","26833328"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Intellectual developmental disorder 99 MIM#300919","syndromic, female-restricted Intellectual developmental disorder 99 MIM#300968"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:12651","gene_name":"valyl-tRNA synthetase","omim_gene":["192150"],"alias_name":["valine tRNA ligase 1, cytoplasmic"],"gene_symbol":"VARS","hgnc_symbol":"VARS","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"6:31745295-31763730","ensembl_id":"ENSG00000204394"}},"GRch38":{"90":{"location":"6:31777518-31795953","ensembl_id":"ENSG00000204394"}}},"hgnc_date_symbol_changed":"2005-07-05"},"entity_type":"gene","entity_name":"VARS","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["30755616","30755602","26539891","29691655","30275004","30755616"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy MIM#617802"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["DKFZP434L1435","KIAA1885","G7a"],"biotype":"protein_coding","hgnc_id":"HGNC:21642","gene_name":"valyl-tRNA synthetase 2, mitochondrial","omim_gene":["612802"],"alias_name":["valine tRNA ligase 2, mitochondrial"],"gene_symbol":"VARS2","hgnc_symbol":"VARS2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"6:30876019-30894236","ensembl_id":"ENSG00000137411"}},"GRch38":{"90":{"location":"6:30908242-30926459","ensembl_id":"ENSG00000137411"}}},"hgnc_date_symbol_changed":"2007-02-23"},"entity_type":"gene","entity_name":"VARS2","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["31064326"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Combined oxidative phosphorylation deficiency 20 MIM#615917"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["VIPAR","VPS16B","SPE-39","SPE39","hSPE-39"],"biotype":"protein_coding","hgnc_id":"HGNC:20347","gene_name":"VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog","omim_gene":["613401"],"alias_name":["VPS33B interacting protein, apical-basolateral polarity regulator"],"gene_symbol":"VIPAS39","hgnc_symbol":"VIPAS39","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"14:77893018-77924295","ensembl_id":"ENSG00000151445"}},"GRch38":{"90":{"location":"14:77426675-77457952","ensembl_id":"ENSG00000151445"}}},"hgnc_date_symbol_changed":"2012-07-24"},"entity_type":"gene","entity_name":"VIPAS39","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["20190753","35151346"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:23663","gene_name":"vitamin K epoxide reductase complex subunit 1","omim_gene":["608547"],"alias_name":null,"gene_symbol":"VKORC1","hgnc_symbol":"VKORC1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"16:31102163-31107301","ensembl_id":"ENSG00000167397"}},"GRch38":{"90":{"location":"16:31090842-31095980","ensembl_id":"ENSG00000167397"}}},"hgnc_date_symbol_changed":"2004-02-04"},"entity_type":"gene","entity_name":"VKORC1","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["12704386","14765194","24963046","18315553"],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Vitamin K-dependent clotting factors, combined deficiency of, 2, MIM#607473"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["CARMQ1","CHRMQ1","VLDLRCH"],"biotype":"protein_coding","hgnc_id":"HGNC:12698","gene_name":"very low density lipoprotein receptor","omim_gene":["192977"],"alias_name":null,"gene_symbol":"VLDLR","hgnc_symbol":"VLDLR","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:2621834-2660053","ensembl_id":"ENSG00000147852"}},"GRch38":{"90":{"location":"9:2621834-2660053","ensembl_id":"ENSG00000147852"}}},"hgnc_date_symbol_changed":"1993-09-24"},"entity_type":"gene","entity_name":"VLDLR","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["16080122","18326629","10380922"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome MIM#224050"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["XMEA"],"biotype":"protein_coding","hgnc_id":"HGNC:22082","gene_name":"VMA21, vacuolar ATPase assembly factor","omim_gene":["300913"],"alias_name":null,"gene_symbol":"VMA21","hgnc_symbol":"VMA21","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:150564987-150577836","ensembl_id":"ENSG00000160131"}},"GRch38":{"90":{"location":"X:151396515-151409364","ensembl_id":"ENSG00000160131"}}},"hgnc_date_symbol_changed":"2009-01-10"},"entity_type":"gene","entity_name":"VMA21","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["27916343","25809233","23315026","36553512"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Myopathy, X-linked, with excessive autophagy MIM#310440"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["RNF108","PEP5"],"biotype":"protein_coding","hgnc_id":"HGNC:14583","gene_name":"VPS11, CORVET/HOPS core subunit","omim_gene":["608549"],"alias_name":null,"gene_symbol":"VPS11","hgnc_symbol":"VPS11","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"11:118938403-118952688","ensembl_id":"ENSG00000160695"}},"GRch38":{"90":{"location":"11:119067692-119081978","ensembl_id":"ENSG00000160695"}}},"hgnc_date_symbol_changed":"2001-02-08"},"entity_type":"gene","entity_name":"VPS11","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["26307567","26307567","27473128","11250079","33452836"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Leukodystrophy, hypomyelinating, 12, 616683 (3), Autosomal recessive"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":["founder"],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["KIAA0986"],"biotype":"protein_coding","hgnc_id":"HGNC:1908","gene_name":"vacuolar protein sorting 13 homolog A","omim_gene":["605978"],"alias_name":["chorein"],"gene_symbol":"VPS13A","hgnc_symbol":"VPS13A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:79792269-80036457","ensembl_id":"ENSG00000197969"}},"GRch38":{"90":{"location":"9:77177353-77421541","ensembl_id":"ENSG00000197969"}}},"hgnc_date_symbol_changed":"2004-02-11"},"entity_type":"gene","entity_name":"VPS13A","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["29518281","28446873"],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Choreoacanthocytosis, 200150 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:2183","gene_name":"vacuolar protein sorting 13 homolog B","omim_gene":["607817"],"alias_name":null,"gene_symbol":"VPS13B","hgnc_symbol":"VPS13B","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"8:100025494-100889808","ensembl_id":"ENSG00000132549"}},"GRch38":{"90":{"location":"8:99013266-99877580","ensembl_id":"ENSG00000132549"}}},"hgnc_date_symbol_changed":"2005-04-08"},"entity_type":"gene","entity_name":"VPS13B","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["37692084","19533689","29758347","19006247"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Cohen syndrome, MIM# 216550"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FLJ14848"],"biotype":"protein_coding","hgnc_id":"HGNC:12712","gene_name":"VPS33B, late endosome and lysosome associated","omim_gene":["608552"],"alias_name":null,"gene_symbol":"VPS33B","hgnc_symbol":"VPS33B","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"15:91541646-91565833","ensembl_id":"ENSG00000184056"}},"GRch38":{"90":{"location":"15:90998416-91022603","ensembl_id":"ENSG00000184056"}}},"hgnc_date_symbol_changed":"1999-11-19"},"entity_type":"gene","entity_name":"VPS33B","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["31479177","30561130","28017832"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Arthrogryposis, renal dysfunction, and cholestasis 1 MIM#208085","Cholestasis, progressive familial intrahepatic, 12 MIM#620010","Keratoderma-ichthyosis-deafness syndrome, autosomal recessive MIM#620009"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FLJ32642","HCRP1","SPG53"],"biotype":"protein_coding","hgnc_id":"HGNC:24928","gene_name":"VPS37A, ESCRT-I subunit","omim_gene":["609927"],"alias_name":["hepatocellular carcinoma related protein 1"],"gene_symbol":"VPS37A","hgnc_symbol":"VPS37A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"8:17104080-17159936","ensembl_id":"ENSG00000155975"}},"GRch38":{"90":{"location":"8:17246571-17302427","ensembl_id":"ENSG00000155975"}}},"hgnc_date_symbol_changed":"2005-09-08"},"entity_type":"gene","entity_name":"VPS37A","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["22717650","29473047"],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Spastic paraplegia 53, autosomal recessive, 614898 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["h-vps45","H1"],"biotype":"protein_coding","hgnc_id":"HGNC:14579","gene_name":"vacuolar protein sorting 45 homolog","omim_gene":["610035"],"alias_name":null,"gene_symbol":"VPS45","hgnc_symbol":"VPS45","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"1:150039369-150117505","ensembl_id":"ENSG00000136631"}},"GRch38":{"90":{"location":"1:150067293-150145327","ensembl_id":"ENSG00000136631"}}},"hgnc_date_symbol_changed":"2006-12-19"},"entity_type":"gene","entity_name":"VPS45","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["30294941"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Neutropenia, severe congenital, 5, autosomal recessive, MIM#615285"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FLJ10979","HCCS1"],"biotype":"protein_coding","hgnc_id":"HGNC:25608","gene_name":"VPS53, GARP complex subunit","omim_gene":["615850"],"alias_name":null,"gene_symbol":"VPS53","hgnc_symbol":"VPS53","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"17:411908-624957","ensembl_id":"ENSG00000141252"}},"GRch38":{"90":{"location":"17:508668-721717","ensembl_id":"ENSG00000141252"}}},"hgnc_date_symbol_changed":"2005-11-29"},"entity_type":"gene","entity_name":"VPS53","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["12920088","24577744","30100179"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Pontocerebellar hypoplasia, type 2E, MIM#615851"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":["founder"],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:12718","gene_name":"vaccinia related kinase 1","omim_gene":["602168"],"alias_name":null,"gene_symbol":"VRK1","hgnc_symbol":"VRK1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"14:97263641-97398059","ensembl_id":"ENSG00000100749"}},"GRch38":{"90":{"location":"14:96797304-96931722","ensembl_id":"ENSG00000100749"}}},"hgnc_date_symbol_changed":"1997-06-12"},"entity_type":"gene","entity_name":"VRK1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["38554151","19646678","21937992","25609612","24126608","27281532","34169149","26583493"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Pontocerebellar hypoplasia type 1A, MIM# 607596, MONDO:0011866","Neuronopathy, distal hereditary motor, autosomal recessive 10, MIM# 620542"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["RET1"],"biotype":"protein_coding","hgnc_id":"HGNC:1975","gene_name":"visual system homeobox 2","omim_gene":["142993"],"alias_name":null,"gene_symbol":"VSX2","hgnc_symbol":"VSX2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"14:74706175-74729441","ensembl_id":"ENSG00000119614"}},"GRch38":{"90":{"location":"14:74239472-74262738","ensembl_id":"ENSG00000119614"}}},"hgnc_date_symbol_changed":"2007-08-21"},"entity_type":"gene","entity_name":"VSX2","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["15257456","8630490","17661825","3378363","10932181"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Microphthalmia with coloboma 3, MIM# 610092","Microphthalmia, isolated 2, MIM# 610093"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:12726","gene_name":"von Willebrand factor","omim_gene":["613160"],"alias_name":null,"gene_symbol":"VWF","hgnc_symbol":"VWF","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"12:6058040-6233936","ensembl_id":"ENSG00000110799"}},"GRch38":{"90":{"location":"12:5948874-6124770","ensembl_id":"ENSG00000110799"}}},"hgnc_date_symbol_changed":"1986-01-01"},"entity_type":"gene","entity_name":"VWF","confidence_level":"2","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Amber","Mackenzie's Mission"],"phenotypes":["von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["TrpRS"],"biotype":"protein_coding","hgnc_id":"HGNC:12730","gene_name":"tryptophanyl tRNA synthetase 2, mitochondrial","omim_gene":["604733"],"alias_name":["tryptophan tRNA ligase 2, mitochondrial"],"gene_symbol":"WARS2","hgnc_symbol":"WARS2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"1:119573839-119683294","ensembl_id":"ENSG00000116874"}},"GRch38":{"90":{"location":"1:119031216-119140671","ensembl_id":"ENSG00000116874"}}},"hgnc_date_symbol_changed":"1999-06-11"},"entity_type":"gene","entity_name":"WARS2","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["37107582","37824696"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures MIM#617710","Parkinsonism-dystonia 3, childhood-onset MIM#619738"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["WASP","WASPA"],"biotype":"protein_coding","hgnc_id":"HGNC:12731","gene_name":"Wiskott-Aldrich syndrome","omim_gene":["300392"],"alias_name":["eczema-thrombocytopenia"],"gene_symbol":"WAS","hgnc_symbol":"WAS","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:48534985-48549818","ensembl_id":"ENSG00000015285"}},"GRch38":{"90":{"location":"X:48676596-48691427","ensembl_id":"ENSG00000015285"}}},"hgnc_date_symbol_changed":"2001-06-22"},"entity_type":"gene","entity_name":"WAS","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["12969986","23689198","20301357","34307257"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Neutropenia, severe congenital, X-linked, MIM#300299","Thrombocytopenia, X-linked, MIM#313900","Wiskott-Aldrich syndrome, MIM#301000"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["Pwdmp","KIAA1638","FLJ23127","ORF26","DYF-2","Oseg6","IFT144","NPHP13"],"biotype":"protein_coding","hgnc_id":"HGNC:18340","gene_name":"WD repeat domain 19","omim_gene":["608151"],"alias_name":["intraflagellar transport 144 homolog (Chlamydomonas)"],"gene_symbol":"WDR19","hgnc_symbol":"WDR19","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"4:39184024-39287430","ensembl_id":"ENSG00000157796"}},"GRch38":{"90":{"location":"4:39182404-39285810","ensembl_id":"ENSG00000157796"}}},"hgnc_date_symbol_changed":"2002-04-26"},"entity_type":"gene","entity_name":"WDR19","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["38163131","22019273"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Nephronophthisis 13, MIM# 614377","Senior-Loken syndrome 8, MIM# 616307","Short-rib thoracic dysplasia 5 with or without polydactyly, MIM# 614376","Cranioectodermal dysplasia 4, MIM# 614378"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["DIC5","MGC20486","bA216B9.3","FAP133"],"biotype":"protein_coding","hgnc_id":"HGNC:28296","gene_name":"WD repeat domain 34","omim_gene":["613363"],"alias_name":null,"gene_symbol":"WDR34","hgnc_symbol":"WDR34","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:131395940-131419066","ensembl_id":"ENSG00000119333"}},"GRch38":{"90":{"location":"9:128633661-128656787","ensembl_id":"ENSG00000119333"}}},"hgnc_date_symbol_changed":"2013-02-19"},"entity_type":"gene","entity_name":"WDR34","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["24183449","24183451","33124039","30649997","29241935","28379358"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Short-rib thoracic dysplasia 11 with or without polydactyly MIM# 615633, MONDO:0014287"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["MGC33196","KIAA1336","IFT121","IFTA1"],"biotype":"protein_coding","hgnc_id":"HGNC:29250","gene_name":"WD repeat domain 35","omim_gene":["613602"],"alias_name":null,"gene_symbol":"WDR35","hgnc_symbol":"WDR35","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:20110021-20189892","ensembl_id":"ENSG00000118965"}},"GRch38":{"90":{"location":"2:19910260-19990131","ensembl_id":"ENSG00000118965"}}},"hgnc_date_symbol_changed":"2004-03-02"},"entity_type":"gene","entity_name":"WDR35","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["33421337","29134781","28870638","26691894","24027799","21473986"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Cranioectodermal dysplasia 2 MIM#613610","Short-rib thoracic dysplasia 7 with or without polydactyly MIM#614091"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["WIPI3"],"biotype":"protein_coding","hgnc_id":"HGNC:25072","gene_name":"WD repeat domain 45B","omim_gene":["609226"],"alias_name":null,"gene_symbol":"WDR45B","hgnc_symbol":"WDR45B","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"17:80572438-80606429","ensembl_id":"ENSG00000141580"}},"GRch38":{"90":{"location":"17:82614562-82648553","ensembl_id":"ENSG00000141580"}}},"hgnc_date_symbol_changed":"2013-01-11"},"entity_type":"gene","entity_name":"WDR45B","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["21937992","28503735","27431290"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures, 617977 (3), Autosomal recessive"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FLJ10300","FAP163"],"biotype":"protein_coding","hgnc_id":"HGNC:21862","gene_name":"WD repeat domain 60","omim_gene":["615462"],"alias_name":null,"gene_symbol":"WDR60","hgnc_symbol":"WDR60","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"7:158649269-158749438","ensembl_id":"ENSG00000126870"}},"GRch38":{"90":{"location":"7:158856578-158956747","ensembl_id":"ENSG00000126870"}}},"hgnc_date_symbol_changed":"2005-04-19"},"entity_type":"gene","entity_name":"WDR60","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["23910462","29271569","26874042","37228654"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["DKFZP434J046","FLJ33298"],"biotype":"protein_coding","hgnc_id":"HGNC:24502","gene_name":"WD repeat domain 62","omim_gene":["613583"],"alias_name":null,"gene_symbol":"WDR62","hgnc_symbol":"WDR62","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"19:36545783-36596008","ensembl_id":"ENSG00000075702"}},"GRch38":{"90":{"location":"19:36054881-36105106","ensembl_id":"ENSG00000075702"}}},"hgnc_date_symbol_changed":"2005-05-09"},"entity_type":"gene","entity_name":"WDR62","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["20890279","20890278","20729831","21496009","21834044","22775483","32677750"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, MIM #604317"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FLJ14888","HSPC264"],"biotype":"protein_coding","hgnc_id":"HGNC:25928","gene_name":"WD repeat domain 73","omim_gene":["616144"],"alias_name":null,"gene_symbol":"WDR73","hgnc_symbol":"WDR73","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"15:85185999-85197574","ensembl_id":"ENSG00000177082"}},"GRch38":{"90":{"location":"15:84639281-84654343","ensembl_id":"ENSG00000177082"}}},"hgnc_date_symbol_changed":"2005-05-26"},"entity_type":"gene","entity_name":"WDR73","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["25466283","26123727","25873735","26070982","30315938"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Galloway-Mowat syndrome 1, MIM# 251300"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FLJ33817","PPP1R166","CAMRQ2","SORF-2"],"biotype":"protein_coding","hgnc_id":"HGNC:26600","gene_name":"WD repeat domain 81","omim_gene":["614218"],"alias_name":["protein phosphatase 1, regulatory subunit 166"],"gene_symbol":"WDR81","hgnc_symbol":"WDR81","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"17:1619817-1641893","ensembl_id":"ENSG00000167716"}},"GRch38":{"90":{"location":"17:1716523-1738599","ensembl_id":"ENSG00000167716"}}},"hgnc_date_symbol_changed":"2005-12-16"},"entity_type":"gene","entity_name":"WDR81","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["28556411","21885617","33724704"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2 MIM#610185, MONDO:0012430","Hydrocephalus, congenital, 3, with brain anomalies MIM#617967, MONDO:0054794"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["DIDMOAD","WFS"],"biotype":"protein_coding","hgnc_id":"HGNC:12762","gene_name":"wolframin ER transmembrane glycoprotein","omim_gene":["606201"],"alias_name":null,"gene_symbol":"WFS1","hgnc_symbol":"WFS1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"4:6271576-6304992","ensembl_id":"ENSG00000109501"}},"GRch38":{"90":{"location":"4:6269849-6303265","ensembl_id":"ENSG00000109501"}}},"hgnc_date_symbol_changed":"1995-01-30"},"entity_type":"gene","entity_name":"WFS1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["20301750","33946243"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Wolfram syndrome 1 MIM#222300"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["CIP98","USH2D","PDZD7B"],"biotype":"protein_coding","hgnc_id":"HGNC:16361","gene_name":"whirlin","omim_gene":["607928"],"alias_name":null,"gene_symbol":"WHRN","hgnc_symbol":"WHRN","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:117164360-117267730","ensembl_id":"ENSG00000095397"}},"GRch38":{"90":{"location":"9:114402080-114505450","ensembl_id":"ENSG00000095397"}}},"hgnc_date_symbol_changed":"2016-05-17"},"entity_type":"gene","entity_name":"WHRN","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["26307081","26338283","22147658","17171570","21738389","27117407"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Usher syndrome, type 2D, MIM#611383"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["CCN6"],"biotype":"protein_coding","hgnc_id":"HGNC:12771","gene_name":"WNT1 inducible signaling pathway protein 3","omim_gene":["603400"],"alias_name":null,"gene_symbol":"WISP3","hgnc_symbol":"WISP3","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"6:112375275-112392171","ensembl_id":"ENSG00000112761"}},"GRch38":{"90":{"location":"6:112054072-112070969","ensembl_id":"ENSG00000112761"}}},"hgnc_date_symbol_changed":"1999-01-22"},"entity_type":"gene","entity_name":"WISP3","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["26610319"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Progressive pseudorheumatoid dysplasia MIM#208230"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":["new gene name"],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["HSAN2","PPP1R167"],"biotype":"protein_coding","hgnc_id":"HGNC:14540","gene_name":"WNK lysine deficient protein kinase 1","omim_gene":["605232"],"alias_name":["protein phosphatase 1, regulatory subunit 167"],"gene_symbol":"WNK1","hgnc_symbol":"WNK1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"12:861759-1020618","ensembl_id":"ENSG00000060237"}},"GRch38":{"90":{"location":"12:752593-911452","ensembl_id":"ENSG00000060237"}}},"hgnc_date_symbol_changed":"2005-01-21"},"entity_type":"gene","entity_name":"WNK1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["15060842","15911806","15455397","16534117","21089229","32790646"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Neuropathy, hereditary sensory and autonomic, type II MIM#201300"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:12774","gene_name":"Wnt family member 1","omim_gene":["164820"],"alias_name":null,"gene_symbol":"WNT1","hgnc_symbol":"WNT1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"12:49372398-49375459","ensembl_id":"ENSG00000125084"}},"GRch38":{"90":{"location":"12:48978453-48981676","ensembl_id":"ENSG00000125084"}}},"hgnc_date_symbol_changed":"2001-06-22"},"entity_type":"gene","entity_name":"WNT1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["23499310"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Osteogenesis imperfecta, type XV, 615220 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["WNT-12","SHFM6"],"biotype":"protein_coding","hgnc_id":"HGNC:12775","gene_name":"Wnt family member 10B","omim_gene":["601906"],"alias_name":null,"gene_symbol":"WNT10B","hgnc_symbol":"WNT10B","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"12:49359123-49365546","ensembl_id":"ENSG00000169884"}},"GRch38":{"90":{"location":"12:48965340-48971763","ensembl_id":"ENSG00000169884"}}},"hgnc_date_symbol_changed":"1997-09-05"},"entity_type":"gene","entity_name":"WNT10B","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["20635353","16688749","29427788","24211389","38058757","39310870"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Split-hand/foot malformation 6, 225300 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:12786","gene_name":"Wnt family member 7A","omim_gene":["601570"],"alias_name":["proto-oncogene Wnt7a protein"],"gene_symbol":"WNT7A","hgnc_symbol":"WNT7A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"3:13857755-13921618","ensembl_id":"ENSG00000154764"}},"GRch38":{"90":{"location":"3:13816258-13880121","ensembl_id":"ENSG00000154764"}}},"hgnc_date_symbol_changed":"1996-03-12"},"entity_type":"gene","entity_name":"WNT7A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["16826533","23922166","28855715"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Fuhrmann syndrome MIM#228930","Ulna and fibula, absence of, with severe limb deficiency MIM#276820"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FLJ10385","TCAB1"],"biotype":"protein_coding","hgnc_id":"HGNC:25522","gene_name":"WD repeat containing antisense to TP53","omim_gene":["612661"],"alias_name":["telomerase cajal body protein 1","WD-encoding RNA antisense to p53"],"gene_symbol":"WRAP53","hgnc_symbol":"WRAP53","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"17:7589389-7606820","ensembl_id":"ENSG00000141499"}},"GRch38":{"90":{"location":"17:7686071-7703502","ensembl_id":"ENSG00000141499"}}},"hgnc_date_symbol_changed":"2009-02-16"},"entity_type":"gene","entity_name":"WRAP53","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["21205863","29514627","32303682"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Dyskeratosis congenita, autosomal recessive 3, 613988 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["RECQL2","RECQ3"],"biotype":"protein_coding","hgnc_id":"HGNC:12791","gene_name":"Werner syndrome RecQ like helicase","omim_gene":["604611"],"alias_name":null,"gene_symbol":"WRN","hgnc_symbol":"WRN","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"8:30891317-31031285","ensembl_id":"ENSG00000165392"}},"GRch38":{"90":{"location":"8:31033801-31173769","ensembl_id":"ENSG00000165392"}}},"hgnc_date_symbol_changed":"1991-08-21"},"entity_type":"gene","entity_name":"WRN","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["8968742","20301687"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Werner syndrome, MIM#277700"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FOR","WOX1","SDR41C1"],"biotype":"protein_coding","hgnc_id":"HGNC:12799","gene_name":"WW domain containing oxidoreductase","omim_gene":["605131"],"alias_name":["short chain dehydrogenase/reductase family 41C, member 1"],"gene_symbol":"WWOX","hgnc_symbol":"WWOX","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"16:78133310-79246564","ensembl_id":"ENSG00000186153"}},"GRch38":{"90":{"location":"16:78099413-79212667","ensembl_id":"ENSG00000186153"}}},"hgnc_date_symbol_changed":"2000-07-31"},"entity_type":"gene","entity_name":"WWOX","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["33916893"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Spinocerebellar ataxia, autosomal recessive 12, MIM# 614322","Developmental and epileptic encephalopathy 28, MIM# 616211"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["hILP"],"biotype":"protein_coding","hgnc_id":"HGNC:592","gene_name":"X-linked inhibitor of apoptosis","omim_gene":["300079"],"alias_name":null,"gene_symbol":"XIAP","hgnc_symbol":"XIAP","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:122993574-123047829","ensembl_id":"ENSG00000101966"}},"GRch38":{"90":{"location":"X:123859724-123913979","ensembl_id":"ENSG00000101966"}}},"hgnc_date_symbol_changed":"2008-03-04"},"entity_type":"gene","entity_name":"XIAP","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["22228567","20489057","17080092","24942515","25943627"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Lymphoproliferative syndorme, X-linked, 2 MIM#300635"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["XPAC","XP1"],"biotype":"protein_coding","hgnc_id":"HGNC:12814","gene_name":"XPA, DNA damage recognition and repair factor","omim_gene":["611153"],"alias_name":null,"gene_symbol":"XPA","hgnc_symbol":"XPA","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:100437191-100459639","ensembl_id":"ENSG00000136936"}},"GRch38":{"90":{"location":"9:97674909-97697357","ensembl_id":"ENSG00000136936"}}},"hgnc_date_symbol_changed":"1990-09-10"},"entity_type":"gene","entity_name":"XPA","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Xeroderma pigmentosum, group A , MIM#278700"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["XPCC","RAD4"],"biotype":"protein_coding","hgnc_id":"HGNC:12816","gene_name":"XPC complex subunit, DNA damage recognition and repair factor","omim_gene":["613208"],"alias_name":["xeroderma pigmentosum group C protein"],"gene_symbol":"XPC","hgnc_symbol":"XPC","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"3:14186647-14220283","ensembl_id":"ENSG00000154767"}},"GRch38":{"90":{"location":"3:14145147-14178783","ensembl_id":"ENSG00000154767"}}},"hgnc_date_symbol_changed":"1992-10-05"},"entity_type":"gene","entity_name":"XPC","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["26255934","8298653"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Xeroderma pigmentosum, group C, 278720 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:12831","gene_name":"X-ray repair cross complementing 4","omim_gene":["194363"],"alias_name":["X-ray repair, complementing defective, repair in Chinese hamster","DNA repair protein XRCC4"],"gene_symbol":"XRCC4","hgnc_symbol":"XRCC4","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"5:82373317-82649606","ensembl_id":"ENSG00000152422"}},"GRch38":{"90":{"location":"5:83077498-83353787","ensembl_id":"ENSG00000152422"}}},"hgnc_date_symbol_changed":"1990-10-16"},"entity_type":"gene","entity_name":"XRCC4","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["24389050","25728776","25872942"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Short stature, microcephaly, and endocrine dysfunction MIM#616541"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["XT-I","PXYLT1"],"biotype":"protein_coding","hgnc_id":"HGNC:15516","gene_name":"xylosyltransferase 1","omim_gene":["608124"],"alias_name":["protein xylosyltransferase 1"],"gene_symbol":"XYLT1","hgnc_symbol":"XYLT1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"16:17195626-17564738","ensembl_id":"ENSG00000103489"}},"GRch38":{"90":{"location":"16:17101769-17470881","ensembl_id":"ENSG00000103489"}}},"hgnc_date_symbol_changed":"2001-04-06"},"entity_type":"gene","entity_name":"XYLT1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["30554721","24581741","23982343","39273648"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Desbuquois dysplasia 2, MIM#615777"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["XT-II","PXYLT2"],"biotype":"protein_coding","hgnc_id":"HGNC:15517","gene_name":"xylosyltransferase 2","omim_gene":["608125"],"alias_name":["protein xylosyltransferase 2"],"gene_symbol":"XYLT2","hgnc_symbol":"XYLT2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"17:48423453-48440499","ensembl_id":"ENSG00000015532"}},"GRch38":{"90":{"location":"17:50346092-50363138","ensembl_id":"ENSG00000015532"}}},"hgnc_date_symbol_changed":"2001-04-06"},"entity_type":"gene","entity_name":"XYLT2","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["34925453","26027496","26987875","30891060","28484880"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Spondyloocular syndrome MIM#605822"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FLJ13995","CGI-04","mt-TyrRS"],"biotype":"protein_coding","hgnc_id":"HGNC:24249","gene_name":"tyrosyl-tRNA synthetase 2","omim_gene":["610957"],"alias_name":["tyrosine tRNA ligase 2, mitochondrial"],"gene_symbol":"YARS2","hgnc_symbol":"YARS2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"12:32880424-32908836","ensembl_id":"ENSG00000139131"}},"GRch38":{"90":{"location":"12:32727490-32755902","ensembl_id":"ENSG00000139131"}}},"hgnc_date_symbol_changed":"2005-06-28"},"entity_type":"gene","entity_name":"YARS2","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["24430573","24344687","32183361"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["ZAP-70","STD"],"biotype":"protein_coding","hgnc_id":"HGNC:12858","gene_name":"zeta chain of T-cell receptor associated protein kinase 70","omim_gene":["176947"],"alias_name":["tyrosine-protein kinase ZAP-70"],"gene_symbol":"ZAP70","hgnc_symbol":"ZAP70","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:98330023-98356325","ensembl_id":"ENSG00000115085"}},"GRch38":{"90":{"location":"2:97713560-97739862","ensembl_id":"ENSG00000115085"}}},"hgnc_date_symbol_changed":"1995-05-16"},"entity_type":"gene","entity_name":"ZAP70","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["8124727","8202712","11412303","26783323","33628209","33531381"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Autoimmune disease, multisystem, infantile-onset, 2 MIM#617006","Immunodeficiency 48 MIM#269840"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["KIAA0441","BIF1","PATZ2"],"biotype":"protein_coding","hgnc_id":"HGNC:21143","gene_name":"zinc finger and BTB domain containing 24","omim_gene":["614064"],"alias_name":["POZ (BTB) and AT hook containing zinc finger 2"],"gene_symbol":"ZBTB24","hgnc_symbol":"ZBTB24","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"6:109783797-109804440","ensembl_id":"ENSG00000112365"}},"GRch38":{"90":{"location":"6:109462594-109483237","ensembl_id":"ENSG00000112365"}}},"hgnc_date_symbol_changed":"2004-04-16"},"entity_type":"gene","entity_name":"ZBTB24","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["23486536"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Immunodeficiency-centromeric instability-facial anomalies syndrome 2, MIM# 614069","MONDO:0013553"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["HCA127"],"biotype":"protein_coding","hgnc_id":"HGNC:24931","gene_name":"zinc finger C4H2-type containing","omim_gene":["300897"],"alias_name":null,"gene_symbol":"ZC4H2","hgnc_symbol":"ZC4H2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:64136250-64254593","ensembl_id":"ENSG00000126970"}},"GRch38":{"90":{"location":"X:64915802-65034713","ensembl_id":"ENSG00000126970"}}},"hgnc_date_symbol_changed":"2008-10-01"},"entity_type":"gene","entity_name":"ZC4H2","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["31206972","37010288"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Wieacker-Wolff syndrome MIM#314580"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["ZNF379","CGI-89","ZNF380"],"biotype":"protein_coding","hgnc_id":"HGNC:18475","gene_name":"zinc finger DHHC-type containing 9","omim_gene":["300646"],"alias_name":null,"gene_symbol":"ZDHHC9","hgnc_symbol":"ZDHHC9","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:128937264-128977885","ensembl_id":"ENSG00000188706"}},"GRch38":{"90":{"location":"X:129803288-129843909","ensembl_id":"ENSG00000188706"}}},"hgnc_date_symbol_changed":"2002-04-05"},"entity_type":"gene","entity_name":"ZDHHC9","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["26000327","29681091","28687527"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Syndromic X-linked intellectual disability, Raymond type MIM#300799 MONDO:0010427"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["KIAA0321"],"biotype":"protein_coding","hgnc_id":"HGNC:20761","gene_name":"zinc finger FYVE-type containing 26","omim_gene":["612012"],"alias_name":["spastizin","FYVE-CENT"],"gene_symbol":"ZFYVE26","hgnc_symbol":"ZFYVE26","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"14:68194091-68283307","ensembl_id":"ENSG00000072121"}},"GRch38":{"90":{"location":"14:67727374-67816590","ensembl_id":"ENSG00000072121"}}},"hgnc_date_symbol_changed":"2003-04-01"},"entity_type":"gene","entity_name":"ZFYVE26","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["34057829","33033739"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Spastic paraplegia 15, autosomal recessive, 270700 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["HTX","ZNF203"],"biotype":"protein_coding","hgnc_id":"HGNC:12874","gene_name":"Zic family member 3","omim_gene":["300265"],"alias_name":null,"gene_symbol":"ZIC3","hgnc_symbol":"ZIC3","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:136648301-136659850","ensembl_id":"ENSG00000156925"}},"GRch38":{"90":{"location":"X:137566142-137577691","ensembl_id":"ENSG00000156925"}}},"hgnc_date_symbol_changed":"1993-11-16"},"entity_type":"gene","entity_name":"ZIC3","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["29442328","27406248","20452998"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Congenital heart defects, nonsyndromic, 1, X-linked (MIM#306955)","Heterotaxy, visceral, 1, X-linked (MIM#306955, MONDO:0010607)","VACTERL association, X-linked, MIM# 314390, MONDO:0010752"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FACE-1","Ste24p","STE24","HGPS","PRO1"],"biotype":"protein_coding","hgnc_id":"HGNC:12877","gene_name":"zinc metallopeptidase STE24","omim_gene":["606480"],"alias_name":["Hutchinson-Gilford progeria syndrome","CAAX prenyl protease 1 homolog"],"gene_symbol":"ZMPSTE24","hgnc_symbol":"ZMPSTE24","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"1:40723779-40759856","ensembl_id":"ENSG00000084073"}},"GRch38":{"90":{"location":"1:40258107-40294184","ensembl_id":"ENSG00000084073"}}},"hgnc_date_symbol_changed":"1999-09-17"},"entity_type":"gene","entity_name":"ZMPSTE24","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["11923874","22718200","29794150","29208544","12913070","27410998","27409638","15937076","16671095","22718200","29794150","24169522"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Mandibuloacral dysplasia with type B lipodystrophy, MIM# 608612","Restrictive dermopathy, lethal, MIM# 275210"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["BLU","CILD22"],"biotype":"protein_coding","hgnc_id":"HGNC:19412","gene_name":"zinc finger MYND-type containing 10","omim_gene":["607070"],"alias_name":null,"gene_symbol":"ZMYND10","hgnc_symbol":"ZMYND10","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"3:50378541-50384283","ensembl_id":"ENSG00000004838"}},"GRch38":{"90":{"location":"3:50341110-50346852","ensembl_id":"ENSG00000004838"}}},"hgnc_date_symbol_changed":"2003-05-01"},"entity_type":"gene","entity_name":"ZMYND10","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["23891471","23891469"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Ciliary dyskinesia, primary, 22 (MIM#615444)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["bA465L10.2","NIF-1"],"biotype":"protein_coding","hgnc_id":"HGNC:15807","gene_name":"zinc finger protein 335","omim_gene":["610827"],"alias_name":["NRC-interacting factor 1"],"gene_symbol":"ZNF335","hgnc_symbol":"ZNF335","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"20:44577292-44600833","ensembl_id":"ENSG00000198026"}},"GRch38":{"90":{"location":"20:45948653-45972172","ensembl_id":"ENSG00000198026"}}},"hgnc_date_symbol_changed":"2001-09-17"},"entity_type":"gene","entity_name":"ZNF335","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["38549403","27540107","29652087","34982360"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Microcephaly 10, primary, autosomal recessive, MIM# 615095"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["CMPX1","ZNF4","ZNF5","dJ75N13.1","Zfp711","MRX97"],"biotype":"protein_coding","hgnc_id":"HGNC:13128","gene_name":"zinc finger protein 711","omim_gene":["314990"],"alias_name":null,"gene_symbol":"ZNF711","hgnc_symbol":"ZNF711","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:84498997-84528368","ensembl_id":"ENSG00000147180"}},"GRch38":{"90":{"location":"X:85244032-85273362","ensembl_id":"ENSG00000147180"}}},"hgnc_date_symbol_changed":"2006-06-29"},"entity_type":"gene","entity_name":"ZNF711","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Intellectual developmental disorder, X-linked 97, MIM# 300803"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":null,"hgnc_id":"HGNC:12309","gene_name":"zinc finger HIT-type containing 3","omim_gene":["604500"],"alias_name":null,"gene_symbol":"ZNHIT3","hgnc_symbol":"ZNHIT3","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"17:34842473-34855154","ensembl_id":"ENSG00000108278"}},"GRch38":{"90":{"location":"17:36486629-36499310","ensembl_id":"ENSG00000273611"}}},"hgnc_date_symbol_changed":"2005-09-08"},"entity_type":"gene","entity_name":"ZNHIT3","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["39252897"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["PEHO syndrome MIM#260565"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["B9","EPPB9","MKS9"],"biotype":"protein_coding","hgnc_id":"HGNC:24123","gene_name":"B9 domain containing 1","omim_gene":["614144"],"alias_name":["endothelial precursor protein B9"],"gene_symbol":"B9D1","hgnc_symbol":"B9D1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"17:19240867-19281495","ensembl_id":"ENSG00000108641"}},"GRch38":{"90":{"location":"17:19337554-19378182","ensembl_id":"ENSG00000108641"}}},"hgnc_date_symbol_changed":"2007-08-21"},"entity_type":"gene","entity_name":"B9D1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["21493627","24886560","25920555","32622957"],"evidence":["Expert Review Green","Literature"],"phenotypes":["Ciliopathy, MONDO:0005308, B9D1-related"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["STL1"],"biotype":"protein_coding","hgnc_id":"HGNC:2200","gene_name":"collagen type II alpha 1 chain","omim_gene":["120140"],"alias_name":null,"gene_symbol":"COL2A1","hgnc_symbol":"COL2A1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"12:48366748-48398269","ensembl_id":"ENSG00000139219"}},"GRch38":{"90":{"location":"12:47972965-48004486","ensembl_id":"ENSG00000139219"}}},"hgnc_date_symbol_changed":"1986-01-01"},"entity_type":"gene","entity_name":"COL2A1","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["32896647","31755234"],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Spondyloperipheral dysplasia, MIM #271700"],"mode_of_inheritance":"BOTH monoallelic and biallelic, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["DIC74"],"biotype":"protein_coding","hgnc_id":"HGNC:2964","gene_name":"dynein cytoplasmic 1 intermediate chain 2","omim_gene":["603331"],"alias_name":null,"gene_symbol":"DYNC1I2","hgnc_symbol":"DYNC1I2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:172543919-172604930","ensembl_id":"ENSG00000077380"}},"GRch38":{"90":{"location":"2:171687409-171748420","ensembl_id":"ENSG00000077380"}}},"hgnc_date_symbol_changed":"2005-11-24"},"entity_type":"gene","entity_name":"DYNC1I2","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["31079899"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Neurodevelopmental disorder with microcephaly and structural brain anomalies\t, MIM#618492"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["HER3"],"biotype":"protein_coding","hgnc_id":"HGNC:3431","gene_name":"erb-b2 receptor tyrosine kinase 3","omim_gene":["190151"],"alias_name":["human epidermal growth factor receptor 3"],"gene_symbol":"ERBB3","hgnc_symbol":"ERBB3","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"12:56473641-56497289","ensembl_id":"ENSG00000065361"}},"GRch38":{"90":{"location":"12:56079857-56103505","ensembl_id":"ENSG00000065361"}}},"hgnc_date_symbol_changed":"1990-07-15"},"entity_type":"gene","entity_name":"ERBB3","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["17701904","31752936","33497358","12548738","38009810"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Visceral neuropathy, familial, 1, autosomal recessive MIM#243180","Lethal congenital contractural syndrome 2 MIM#607598"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["minK","ISK","JLNS2","LQT5"],"biotype":"protein_coding","hgnc_id":"HGNC:6240","gene_name":"potassium voltage-gated channel subfamily E regulatory subunit 1","omim_gene":["176261"],"alias_name":null,"gene_symbol":"KCNE1","hgnc_symbol":"KCNE1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"21:35818988-35884573","ensembl_id":"ENSG00000180509"}},"GRch38":{"90":{"location":"21:34446688-34512275","ensembl_id":"ENSG00000180509"}}},"hgnc_date_symbol_changed":"1991-08-13"},"entity_type":"gene","entity_name":"KCNE1","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Jervell and Lange-Nielsen syndrome 2, MIM# 612347"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["S1P","KIAA0091","SKI-1","PCSK8"],"biotype":"protein_coding","hgnc_id":"HGNC:15456","gene_name":"membrane bound transcription factor peptidase, site 1","omim_gene":["603355"],"alias_name":["subtilisin kexin isozyme 1","site-1 protease"],"gene_symbol":"MBTPS1","hgnc_symbol":"MBTPS1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"16:84087368-84150511","ensembl_id":"ENSG00000140943"}},"GRch38":{"90":{"location":"16:84053761-84116906","ensembl_id":"ENSG00000140943"}}},"hgnc_date_symbol_changed":"2001-03-30"},"entity_type":"gene","entity_name":"MBTPS1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["32857899","30046013","32420688"],"evidence":["Expert Review Green","Expert Review","Literature"],"phenotypes":["Spondyloepiphyseal dysplasia, Kondo-Fu type MIM#618392"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["GCS1","CWH41","DER7"],"biotype":"protein_coding","hgnc_id":"HGNC:24862","gene_name":"mannosyl-oligosaccharide glucosidase","omim_gene":["601336"],"alias_name":["glucosidase I","processing A-glucosidase I"],"gene_symbol":"MOGS","hgnc_symbol":"MOGS","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:74688184-74692537","ensembl_id":"ENSG00000115275"}},"GRch38":{"90":{"location":"2:74461057-74465410","ensembl_id":"ENSG00000115275"}}},"hgnc_date_symbol_changed":"2009-03-24"},"entity_type":"gene","entity_name":"MOGS","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["31925597","30587846","33058492","38498292","33261925"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Congenital disorder of glycosylation, type IIb, MIM# 606056"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["KIAA1857","Lmnt2"],"biotype":"protein_coding","hgnc_id":"HGNC:14288","gene_name":"netrin G2","omim_gene":null,"alias_name":["Netrin-G2"],"gene_symbol":"NTNG2","hgnc_symbol":"NTNG2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:135037334-135119921","ensembl_id":"ENSG00000196358"}},"GRch38":{"90":{"location":"9:132161676-132244534","ensembl_id":"ENSG00000196358"}}},"hgnc_date_symbol_changed":"2003-12-03"},"entity_type":"gene","entity_name":"NTNG2","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["31692205","31668703"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia, MIM# 618718"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["p180"],"biotype":"protein_coding","hgnc_id":"HGNC:9173","gene_name":"DNA polymerase alpha 1, catalytic subunit","omim_gene":["312040"],"alias_name":null,"gene_symbol":"POLA1","hgnc_symbol":"POLA1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:24712036-25015103","ensembl_id":"ENSG00000101868"}},"GRch38":{"90":{"location":"X:24693919-24996986","ensembl_id":"ENSG00000101868"}}},"hgnc_date_symbol_changed":"2006-09-26"},"entity_type":"gene","entity_name":"POLA1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["27019227","31006512"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Pigmentary disorder, reticulate, with systemic manifestations, X-linked, MIM#301220","Van Esch-O'Driscoll syndrome, MIM #301030"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["NOV","QM","DXS648E","DXS648","FLJ23544","L10"],"biotype":"protein_coding","hgnc_id":"HGNC:10298","gene_name":"ribosomal protein L10","omim_gene":["312173"],"alias_name":null,"gene_symbol":"RPL10","hgnc_symbol":"RPL10","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:153618315-153637504","ensembl_id":"ENSG00000147403"}},"GRch38":{"90":{"location":"X:154389955-154409168","ensembl_id":"ENSG00000147403"}}},"hgnc_date_symbol_changed":"1998-07-23"},"entity_type":"gene","entity_name":"RPL10","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["25316788","26290468","25846674","29066376"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Intellectual developmental disorder, X-linked, syndromic, 35, MIM300998"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:28983","gene_name":"transmembrane protein 94","omim_gene":null,"alias_name":null,"gene_symbol":"TMEM94","hgnc_symbol":"TMEM94","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"17:73437240-73496171","ensembl_id":"ENSG00000177728"}},"GRch38":{"90":{"location":"17:75441159-75500090","ensembl_id":"ENSG00000177728"}}},"hgnc_date_symbol_changed":"2015-10-07"},"entity_type":"gene","entity_name":"TMEM94","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["30526868","32825426"],"evidence":["Expert Review Green","Expert list"],"phenotypes":["Intellectual developmental disorder with cardiac defects and dysmorphic facies, MIM#618316"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":null,"hgnc_id":"HGNC:12029","gene_name":"T-cell receptor alpha constant","omim_gene":["186880"],"alias_name":null,"gene_symbol":"TRAC","hgnc_symbol":"TRAC","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"14:23016447-23021097","ensembl_id":"ENSG00000229164"}},"GRch38":{"90":{"location":"14:22547506-22552154","ensembl_id":"ENSG00000277734"}}},"hgnc_date_symbol_changed":"2000-05-08"},"entity_type":"gene","entity_name":"TRAC","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Immunodeficiency 7, TCR-alpha/beta deficient, 615387 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["APP3","NPHPL1","ICP55"],"biotype":"protein_coding","hgnc_id":"HGNC:28052","gene_name":"X-prolyl aminopeptidase 3","omim_gene":["613553"],"alias_name":["Intermediate Cleaving Peptidase 55"],"gene_symbol":"XPNPEP3","hgnc_symbol":"XPNPEP3","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"22:41253081-41363838","ensembl_id":"ENSG00000196236"}},"GRch38":{"90":{"location":"22:40857077-40932815","ensembl_id":"ENSG00000196236"}}},"hgnc_date_symbol_changed":"2006-08-02"},"entity_type":"gene","entity_name":"XPNPEP3","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Nephronophthisis-like nephropathy 1, 613159 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FFM","ARMD2","CORD3"],"biotype":"protein_coding","hgnc_id":"HGNC:34","gene_name":"ATP binding cassette subfamily A member 4","omim_gene":["601691"],"alias_name":["Stargardt disease"],"gene_symbol":"ABCA4","hgnc_symbol":"ABCA4","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"1:94458393-94586688","ensembl_id":"ENSG00000198691"}},"GRch38":{"90":{"location":"1:93992835-94121132","ensembl_id":"ENSG00000198691"}}},"hgnc_date_symbol_changed":"1994-07-14"},"entity_type":"gene","entity_name":"ABCA4","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Cone-rod dystrophy 3 MIM#604116","Stargardt disease 1 MIM#248200","Retinal dystrophy, early-onset severe MIM#248200"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["MRP6","EST349056","MLP1","URG7"],"biotype":"protein_coding","hgnc_id":"HGNC:57","gene_name":"ATP binding cassette subfamily C member 6","omim_gene":["603234"],"alias_name":null,"gene_symbol":"ABCC6","hgnc_symbol":"ABCC6","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"16:16242785-16317379","ensembl_id":"ENSG00000091262"}},"GRch38":{"90":{"location":"16:16148928-16223522","ensembl_id":"ENSG00000091262"}}},"hgnc_date_symbol_changed":"1997-10-27"},"entity_type":"gene","entity_name":"ABCC6","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Pseudoxanthoma elasticum MIM#264800","Arterial calcification, generalized, of infancy, 2 MIM#614473"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:27288","gene_name":"acyl-CoA synthetase family member 3","omim_gene":["614245"],"alias_name":["malonyl-CoA synthetase"],"gene_symbol":"ACSF3","hgnc_symbol":"ACSF3","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"16:89154783-89222254","ensembl_id":"ENSG00000176715"}},"GRch38":{"90":{"location":"16:89088375-89155846","ensembl_id":"ENSG00000176715"}}},"hgnc_date_symbol_changed":"2007-10-17"},"entity_type":"gene","entity_name":"ACSF3","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["30740739"],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Combined malonic and methylmalonic aciduria, MIM#614265"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:177","gene_name":"aminoacylase 1","omim_gene":["104620"],"alias_name":null,"gene_symbol":"ACY1","hgnc_symbol":"ACY1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"3:52009066-52023213","ensembl_id":"ENSG00000243989"}},"GRch38":{"90":{"location":"3:51983278-51989202","ensembl_id":"ENSG00000243989"}}},"hgnc_date_symbol_changed":"1986-01-01"},"entity_type":"gene","entity_name":"ACY1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["24117009","16465618","16274666","17562838"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Aminoacylase 1 deficiency, MIM# 609924"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["ARH3","FLJ20446"],"biotype":"protein_coding","hgnc_id":"HGNC:21304","gene_name":"ADP-ribosylhydrolase like 2","omim_gene":["610624"],"alias_name":["ADP-ribosylarginine hydrolase like 2"],"gene_symbol":"ADPRHL2","hgnc_symbol":"ADPRHL2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"1:36554476-36559533","ensembl_id":"ENSG00000116863"}},"GRch38":{"90":{"location":"1:36088875-36093932","ensembl_id":"ENSG00000116863"}}},"hgnc_date_symbol_changed":"2003-06-19"},"entity_type":"gene","entity_name":"ADPRHL2","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["30401461","30100084"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures, MIM#618170"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":["new gene name"],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FRAXE"],"biotype":"protein_coding","hgnc_id":"HGNC:3776","gene_name":"AF4/FMR2 family member 2","omim_gene":["300806"],"alias_name":null,"gene_symbol":"AFF2","hgnc_symbol":"AFF2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:147582139-148082193","ensembl_id":"ENSG00000155966"}},"GRch38":{"90":{"location":"X:148500619-149000663","ensembl_id":"ENSG00000155966"}}},"hgnc_date_symbol_changed":"2005-06-27"},"entity_type":"gene","entity_name":"AFF2","confidence_level":"2","penetrance":null,"mode_of_pathogenicity":"","publications":["35431806","8334699","21739600","22773736"],"evidence":["Expert Review Amber","Expert Review"],"phenotypes":["Intellectual disability, X-linked, FRAXE type 309548"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["DXS1357E","BAP31","6C6-Ag","CDM"],"biotype":"protein_coding","hgnc_id":"HGNC:16695","gene_name":"B-cell receptor associated protein 31","omim_gene":["300398"],"alias_name":null,"gene_symbol":"BCAP31","hgnc_symbol":"BCAP31","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:152965947-152990152","ensembl_id":"ENSG00000185825"}},"GRch38":{"90":{"location":"X:153700497-153724697","ensembl_id":"ENSG00000185825"}}},"hgnc_date_symbol_changed":"2003-12-22"},"entity_type":"gene","entity_name":"BCAP31","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["31330203","24011989","33603160"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Deafness, dystonia, and cerebral hypomyelination, MIM# 300475"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["HIP4"],"biotype":"protein_coding","hgnc_id":"HGNC:1550","gene_name":"cystathionine-beta-synthase","omim_gene":["613381"],"alias_name":null,"gene_symbol":"CBS","hgnc_symbol":"CBS","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"21:44473301-44497053","ensembl_id":"ENSG00000160200"}},"GRch38":{"90":{"location":"21:43053191-43076943","ensembl_id":"ENSG00000160200"}}},"hgnc_date_symbol_changed":"2001-06-22"},"entity_type":"gene","entity_name":"CBS","confidence_level":"2","penetrance":null,"mode_of_pathogenicity":"","publications":["7506602","10338090","7967489","27778219"],"evidence":["Expert Review Amber","Mackenzie's Mission"],"phenotypes":["Homocystinuria, B6-responsive and nonresponsive types, MIM#236200"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["TAPA-1","TSPAN28"],"biotype":"protein_coding","hgnc_id":"HGNC:1701","gene_name":"CD81 molecule","omim_gene":["186845"],"alias_name":null,"gene_symbol":"CD81","hgnc_symbol":"CD81","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"11:2397407-2418649","ensembl_id":"ENSG00000110651"}},"GRch38":{"90":{"location":"11:2376177-2397419","ensembl_id":"ENSG00000110651"}}},"hgnc_date_symbol_changed":"1992-10-21"},"entity_type":"gene","entity_name":"CD81","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["20237408","35849269"],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Immunodeficiency, common variable, 6, 613496 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["KIP2"],"biotype":"protein_coding","hgnc_id":"HGNC:24579","gene_name":"calcium and integrin binding family member 2","omim_gene":["605564"],"alias_name":null,"gene_symbol":"CIB2","hgnc_symbol":"CIB2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"15:78396948-78423886","ensembl_id":"ENSG00000136425"}},"GRch38":{"90":{"location":"15:78104606-78131544","ensembl_id":"ENSG00000136425"}}},"hgnc_date_symbol_changed":"2004-04-20"},"entity_type":"gene","entity_name":"CIB2","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["29112224"],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Deafness, autosomal recessive 48\tMIM#609439"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["GTC90"],"biotype":"protein_coding","hgnc_id":"HGNC:14857","gene_name":"component of oligomeric golgi complex 5","omim_gene":["606821"],"alias_name":null,"gene_symbol":"COG5","hgnc_symbol":"COG5","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"7:106842000-107204959","ensembl_id":"ENSG00000164597"}},"GRch38":{"90":{"location":"7:107201555-107564514","ensembl_id":"ENSG00000164597"}}},"hgnc_date_symbol_changed":"2002-05-10"},"entity_type":"gene","entity_name":"COG5","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["32174980","31572517","23228021"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Congenital disorder of glycosylation, type IIi, MIM# 613612"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FLJ13305"],"biotype":"protein_coding","hgnc_id":"HGNC:25808","gene_name":"family with sequence similarity 161 member A","omim_gene":["613596"],"alias_name":null,"gene_symbol":"FAM161A","hgnc_symbol":"FAM161A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:62051989-62081278","ensembl_id":"ENSG00000170264"}},"GRch38":{"90":{"location":"2:61824854-61854143","ensembl_id":"ENSG00000170264"}}},"hgnc_date_symbol_changed":"2008-06-05"},"entity_type":"gene","entity_name":"FAM161A","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Retinitis pigmentosa 28, MIM #606068"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["dJ881L22.2","FIT2"],"biotype":"protein_coding","hgnc_id":"HGNC:16135","gene_name":"fat storage inducing transmembrane protein 2","omim_gene":["612029"],"alias_name":["fat inducing transcript 2"],"gene_symbol":"FITM2","hgnc_symbol":"FITM2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"20:42931478-42939809","ensembl_id":"ENSG00000197296"}},"GRch38":{"90":{"location":"20:44302838-44311169","ensembl_id":"ENSG00000197296"}}},"hgnc_date_symbol_changed":"2009-04-29"},"entity_type":"gene","entity_name":"FITM2","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["30214770","28067622","30288795"],"evidence":["Expert Review Green","Expert list"],"phenotypes":["Siddiqi syndrome MIM#618635"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:4670","gene_name":"GTP binding protein 2","omim_gene":["607434"],"alias_name":null,"gene_symbol":"GTPBP2","hgnc_symbol":"GTPBP2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"6:43573053-43596899","ensembl_id":"ENSG00000172432"}},"GRch38":{"90":{"location":"6:43605316-43629162","ensembl_id":"ENSG00000172432"}}},"hgnc_date_symbol_changed":"2000-07-31"},"entity_type":"gene","entity_name":"GTPBP2","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["30790272","26675814","29449720"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Jaberi-Elahi syndrome, MIM#617988"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["IPM200","RP56"],"biotype":"protein_coding","hgnc_id":"HGNC:18362","gene_name":"interphotoreceptor matrix proteoglycan 2","omim_gene":["607056"],"alias_name":null,"gene_symbol":"IMPG2","hgnc_symbol":"IMPG2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"3:100941390-101039404","ensembl_id":"ENSG00000081148"}},"GRch38":{"90":{"location":"3:101222546-101320560","ensembl_id":"ENSG00000081148"}}},"hgnc_date_symbol_changed":"2002-03-15"},"entity_type":"gene","entity_name":"IMPG2","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["20673862","32242237","37806544","36206764","38217426","32817297","24876279","31264916","34990796"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Retinitis pigmentosa 56, MIM #613801"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["MGC4276","ISA1","hIscA"],"biotype":"protein_coding","hgnc_id":"HGNC:28660","gene_name":"iron-sulfur cluster assembly 1","omim_gene":["611006"],"alias_name":null,"gene_symbol":"ISCA1","hgnc_symbol":"ISCA1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:88879461-88897676","ensembl_id":"ENSG00000135070"}},"GRch38":{"90":{"location":"9:86264546-86283102","ensembl_id":"ENSG00000135070"}}},"hgnc_date_symbol_changed":"2007-01-18"},"entity_type":"gene","entity_name":"ISCA1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["32092383","30113620","30105122","31016283","28356563"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Multiple mitochondrial dysfunctions syndrome 5, MIM#\t617613"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["CD49c","VLA3a","VCA-2","GAP-B3"],"biotype":"protein_coding","hgnc_id":"HGNC:6139","gene_name":"integrin subunit alpha 3","omim_gene":["605025"],"alias_name":["alpha 3 subunit of VLA-3 receptor","antigen CD49C"],"gene_symbol":"ITGA3","hgnc_symbol":"ITGA3","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"17:48133332-48167845","ensembl_id":"ENSG00000005884"}},"GRch38":{"90":{"location":"17:50055968-50090481","ensembl_id":"ENSG00000005884"}}},"hgnc_date_symbol_changed":"1992-02-27"},"entity_type":"gene","entity_name":"ITGA3","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["22512483","25810266","23114595","27717396","32198874","26854491","34492382","34751145"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital, MIM# 614748"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["CARD2","K8","CK8","CYK8","K2C8","KO"],"biotype":"protein_coding","hgnc_id":"HGNC:6446","gene_name":"keratin 8","omim_gene":["148060"],"alias_name":null,"gene_symbol":"KRT8","hgnc_symbol":"KRT8","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"12:53290977-53343738","ensembl_id":"ENSG00000170421"}},"GRch38":{"90":{"location":"12:52897187-52949954","ensembl_id":"ENSG00000170421"}}},"hgnc_date_symbol_changed":"1988-08-12"},"entity_type":"gene","entity_name":"KRT8","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["12724528","11372009","15235035"],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Cirrhosis, cryptogenic, MIM#215600"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["COD5"],"biotype":"protein_coding","hgnc_id":"HGNC:9936","gene_name":"opsin 1, long wave sensitive","omim_gene":["300822"],"alias_name":["cone dystrophy 5 (X-linked)"],"gene_symbol":"OPN1LW","hgnc_symbol":"OPN1LW","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:153409698-153424507","ensembl_id":"ENSG00000102076"}},"GRch38":{"90":{"location":"X:154144224-154159032","ensembl_id":"ENSG00000102076"}}},"hgnc_date_symbol_changed":"2001-06-22"},"entity_type":"gene","entity_name":"OPN1LW","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["25168334","32860923","8213841"],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Blue cone monochromacy, MIM#303700","Colorblindness, protan, MIM#303900"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["CSNB3","rd1","RP40","CSNBAD2"],"biotype":"protein_coding","hgnc_id":"HGNC:8786","gene_name":"phosphodiesterase 6B","omim_gene":["180072"],"alias_name":["congenital stationary night blindness 3, autosomal dominant"],"gene_symbol":"PDE6B","hgnc_symbol":"PDE6B","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"4:619373-664571","ensembl_id":"ENSG00000133256"}},"GRch38":{"90":{"location":"4:625584-670782","ensembl_id":"ENSG00000133256"}}},"hgnc_date_symbol_changed":"1991-01-15"},"entity_type":"gene","entity_name":"PDE6B","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["8394174","8075643","17044014","7599633","18854872","33673512"],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Retinitis pigmentosa-40, MIM #613801"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["PIP5Kgamma","KIAA0589","LCCS3"],"biotype":"protein_coding","hgnc_id":"HGNC:8996","gene_name":"phosphatidylinositol-4-phosphate 5-kinase type 1 gamma","omim_gene":["606102"],"alias_name":null,"gene_symbol":"PIP5K1C","hgnc_symbol":"PIP5K1C","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"19:3630181-3700477","ensembl_id":"ENSG00000186111"}},"GRch38":{"90":{"location":"19:3630183-3700479","ensembl_id":"ENSG00000186111"}}},"hgnc_date_symbol_changed":"1999-12-14"},"entity_type":"gene","entity_name":"PIP5K1C","confidence_level":"2","penetrance":null,"mode_of_pathogenicity":"","publications":["17701898","38491417"],"evidence":["Expert Review Amber","Mackenzie's Mission"],"phenotypes":["Lethal congenital contractural syndrome 3, 611369 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["DKFZP564F0923","KIAA1471","HD-PTP"],"biotype":"protein_coding","hgnc_id":"HGNC:14406","gene_name":"protein tyrosine phosphatase, non-receptor type 23","omim_gene":["606584"],"alias_name":null,"gene_symbol":"PTPN23","hgnc_symbol":"PTPN23","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"3:47422501-47454931","ensembl_id":"ENSG00000076201"}},"GRch38":{"90":{"location":"3:47381011-47413441","ensembl_id":"ENSG00000076201"}}},"hgnc_date_symbol_changed":"2001-02-15"},"entity_type":"gene","entity_name":"PTPN23","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["25558065","31395947","27848944","29899372","29090338"],"evidence":["Expert Review Green","Expert list"],"phenotypes":["Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, MIM# 618890"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["FLJ20485"],"biotype":"protein_coding","hgnc_id":"HGNC:26033","gene_name":"pseudouridylate synthase 7 (putative)","omim_gene":["616261"],"alias_name":null,"gene_symbol":"PUS7","hgnc_symbol":"PUS7","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"7:105080108-105162714","ensembl_id":"ENSG00000091127"}},"GRch38":{"90":{"location":"7:105439661-105522267","ensembl_id":"ENSG00000091127"}}},"hgnc_date_symbol_changed":"2006-02-07"},"entity_type":"gene","entity_name":"PUS7","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["30526862","31583274","30778726"],"evidence":["Expert Review Green","Expert list"],"phenotypes":["OMIM #618342","Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["dJ852M4.2"],"biotype":"protein_coding","hgnc_id":"HGNC:16133","gene_name":"TBC1 domain family member 20","omim_gene":["611663"],"alias_name":null,"gene_symbol":"TBC1D20","hgnc_symbol":"TBC1D20","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"20:416124-443197","ensembl_id":"ENSG00000125875"}},"GRch38":{"90":{"location":"20:435480-462553","ensembl_id":"ENSG00000125875"}}},"hgnc_date_symbol_changed":"2005-01-05"},"entity_type":"gene","entity_name":"TBC1D20","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["32162791","24239381","32740904"],"evidence":["Expert Review Green","Expert list"],"phenotypes":["Martsolf syndrome","Warburg micro syndrome 4, MIM# 615663"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:11600","gene_name":"T-box 22","omim_gene":["300307"],"alias_name":null,"gene_symbol":"TBX22","hgnc_symbol":"TBX22","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:79270255-79287268","ensembl_id":"ENSG00000122145"}},"GRch38":{"90":{"location":"X:80014756-80031769","ensembl_id":"ENSG00000122145"}}},"hgnc_date_symbol_changed":"2000-05-05"},"entity_type":"gene","entity_name":"TBX22","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["36901693","22784330","21375406"],"evidence":["Expert Review Red","Expert Review"],"phenotypes":["Cleft palate with ankyloglossia, MIM #303400"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["dJ101A2.2","prpk","Nori-2p","BUD32"],"biotype":"protein_coding","hgnc_id":"HGNC:16197","gene_name":"TP53 regulating kinase","omim_gene":["608679"],"alias_name":null,"gene_symbol":"TP53RK","hgnc_symbol":"TP53RK","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"20:45313004-45318418","ensembl_id":"ENSG00000172315"}},"GRch38":{"90":{"location":"20:46684365-46689779","ensembl_id":"ENSG00000172315"}}},"hgnc_date_symbol_changed":"2004-05-12"},"entity_type":"gene","entity_name":"TP53RK","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["30053862","28805828"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Galloway-Mowat syndrome 4, MIM# 617730"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["CGI-121","CGI121"],"biotype":"protein_coding","hgnc_id":"HGNC:24259","gene_name":"TP53RK binding protein","omim_gene":["608680"],"alias_name":null,"gene_symbol":"TPRKB","hgnc_symbol":"TPRKB","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:73956231-73964527","ensembl_id":"ENSG00000144034"}},"GRch38":{"90":{"location":"2:73729104-73737400","ensembl_id":"ENSG00000144034"}}},"hgnc_date_symbol_changed":"2006-02-02"},"entity_type":"gene","entity_name":"TPRKB","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["30053862","28805828","30053862"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Galloway-Mowat syndrome 5, MIM# 617731"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":["CGI-87","TTC-15"],"biotype":"protein_coding","hgnc_id":"HGNC:24284","gene_name":"trafficking protein particle complex 12","omim_gene":["614139"],"alias_name":null,"gene_symbol":"TRAPPC12","hgnc_symbol":"TRAPPC12","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:3383446-3488865","ensembl_id":"ENSG00000171853"}},"GRch38":{"90":{"location":"2:3379675-3485094","ensembl_id":"ENSG00000171853"}}},"hgnc_date_symbol_changed":"2011-12-12"},"entity_type":"gene","entity_name":"TRAPPC12","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["32369837","28777934"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Encephalopathy, progressive, early-onset, with brain atrophy and spasticity, MIM# 617669"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:23066","gene_name":"trafficking protein particle complex 6B","omim_gene":["610397"],"alias_name":null,"gene_symbol":"TRAPPC6B","hgnc_symbol":"TRAPPC6B","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"14:39617015-39639736","ensembl_id":"ENSG00000182400"}},"GRch38":{"90":{"location":"14:39147811-39170532","ensembl_id":"ENSG00000182400"}}},"hgnc_date_symbol_changed":"2003-09-01"},"entity_type":"gene","entity_name":"TRAPPC6B","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["28397838","28626029","31687267"],"evidence":["Expert Review Green","Expert Review"],"phenotypes":["Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy, MIM# 617862"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:12382","gene_name":"TSPY like 1","omim_gene":["604714"],"alias_name":null,"gene_symbol":"TSPYL1","hgnc_symbol":"TSPYL1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"6:116597741-116601066","ensembl_id":"ENSG00000189241"}},"GRch38":{"90":{"location":"6:116276578-116279903","ensembl_id":"ENSG00000189241"}}},"hgnc_date_symbol_changed":"2004-04-07"},"entity_type":"gene","entity_name":"TSPYL1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["15273283","19463995","22137496","25449952","16418600","32885560","33075815"],"evidence":["Expert Review Green","Mackenzie's Mission"],"phenotypes":["Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null},{"gene_data":{"alias":[],"biotype":"protein_coding","hgnc_id":"HGNC:12410","gene_name":"tubulin alpha 8","omim_gene":["605742"],"alias_name":null,"gene_symbol":"TUBA8","hgnc_symbol":"TUBA8","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"22:18593097-18629321","ensembl_id":"ENSG00000183785"}},"GRch38":{"90":{"location":"22:18110331-18146554","ensembl_id":"ENSG00000183785"}}},"hgnc_date_symbol_changed":"1999-10-29"},"entity_type":"gene","entity_name":"TUBA8","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["34704371"],"evidence":["Expert Review Red","Mackenzie's Mission"],"phenotypes":["Polymicrogyria with optic nerve hypoplasia MONDO:0013172"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":3861,"hash_id":null,"name":"Prepair 1000+","disease_group":"Screening","disease_sub_group":"","description":"This panel was originally developed as part of the Australian Reproductive Genetic Carrier Screening Research Project, also known as Mackenzie’s Mission (Kirk et al 2020; PMID: 32678339).\r\n\r\nIt has been further revised by Victorian Clinical Genetics Services based on research findings and experience of the clinical and laboratory teams. Genes included are associated with conditions that have an onset in childhood, are able to be screened using existing technology, have a severe impact on the affected individual, and have limited and/or burdensome treatment.\r\n\r\nGenes associated with treatable conditions are only included if the conditions are not covered by newborn screening in Australia.\r\n\r\nPlease note only Green genes are analysed and reported.","status":"public","version":"2.16","version_created":"2026-04-02T17:30:09.498472+11:00","relevant_disorders":[],"stats":{"number_of_genes":1389,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Victorian Clinical Genetics Services","slug":"victorian-clinical-genetics-services","description":"Panel used by VCGS."}],"child_panel_ids":[]},"transcript":null}]}